"By investing in a new industrial site, campus and R&D center, the company wishes to consolidate its ambition of being a world center of excellence for microbiological analysis.said Emmanuel Jalenques, co-director with his brother Jules Jalenques of the company Interscience. The family company, founded in 1979, now employs 140 people, including 78 employees at its historic site in Puycapel where it has its roots.
This project will also create about 50 additional jobs in the Cantal region as well as in its subsidiaries in the USA, China, Singapore, Japan and Germany.
Supported by the BPI and the Stimulus Plan, this new investment, for which the building permit has just been granted, is estimated at a total of around 6 million euros. It will enable the extension of the factory, the expansion of the R&D center and the creation of an industrial campus: construction of several buildings with a total additional surface area of 3000 m2. This expansion will quadruple the production capacity dedicated to the production of ScanStation - a real-time incubation, detection and colony counting station.
Since the launch of ScanStation in 2017, the company has equipped more than 85 sites in 23 countries around the world with one of the three available ScanStation versions.
"There is indeed a strong demand, especially from pharmaceutical groups, which have either expansion projects or new manufacturing sites. These investments project them into the future through strategic choices such as ScanStation. The incubator robot, ScanStation, performs 24/7 microbiological analyses in real time and meets this demand for performance, digitalization and quality. This is why ScanStation sales are doubling every year. The new production facilities will allow us to grow flexibly.explains Jules Jalenques.
Visit the site:
www.interscience.com
